Derivation of system suitability test limits from a robustness test on an LC assay with complex antibiotic samples

Journal of Pharmaceutical and Biomedical Analysis

Volumn 30, Issue 4, 2002, Pages 1197-1206

  Hund, Edelgard ^a   Vander Heyden, Yvan ^a   Massart, D Luc ^a   Smeyers Verbeke, Johanna ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Antibiotic sample; Robustness test; System suitability limit; System suitability test

Indexed keywords

ANTIBIOTIC AGENT; TYLOSIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MICROORGANISM; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLING;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; REPRODUCIBILITY OF RESULTS;

EID: 0037038380     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00470-3     Document Type: Article

References (21)

1. King R.H., Grady L.T., Reamer J.T. J. Pharm. Sci. 63:1974;1591-1596.
2. Dong M., Paul R., Gershanov L. Today's Chemist at Work. 2001;38-42.
3. ICH Topic Q2B Validation of analytical procedures: Methodology. Step 4, consensus guideline, the International conference on Harmonisation of Technical Requirements for registration of Pharmaceuticals for human use, November 6, 1996.
4. Wilson T.D. J. Pharm. Biomed. Anal. 8:1990;389-400.
5. European Pharmacopoeia, third ed., Supplement 2001, European Pharmacopoeia, Strasbourg, 2001, pp. 30-33.
6. The United States Pharmacopoeia, 23rd ed., National Formulary 18, United States Pharmacopoeial convention, Rockville, MD, 1995, pp. 1566.
7. Vander Heyden Y., Jimidar M., Hund E., Niemeijer N., Peeters R., Smeyers-Verbeke J., Massart D.L., Hoogmartens J. J. Chromatogr. A. 845:1999;145-154.
8. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., Massart D.L. J. Pharm. Biomed. Anal. 24:2001;723-753.
9. Chalgeri A., Tan H.S.I. J. Pharm. Biomed. Anal. 14:1996;835-844.
10. Vander Heyden Y., Questier F., Massart D.L. J. Pharm. Biomed. Anal. 17:1998;153-168.
11. European Pharmacopoeia, Third Ed. 1998. SUPPL. 1998. 504-505, European Pharmacopoeia, Strasbourg
12. Paesen J., Cypers W., Pauwels K., Roets E., Hoogmartens J. J. Pharm. Biomed. Anal. 13:1995;1153-1159.
13. Plackett R.L., Burman J.P. Biometrika. 33:1946;305-325.
14. Vander Heyden Y., Massart D.I. Hendriks M.W.B., de Boer J.H., Smilde A.K., Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products. 1996;79-147 Elsevier, Amsterdam.
15. Daniel C. Technometrics. 1:1959;311-341.
16. Nijhuis A., van der Knaap H.C.M., de Jong S., Vandeginste B.G.M. Anal. Chim. Acta. 391:1999;187-202.
17. Hund E., Vander Heyden Y., Haustein M., Massart D.L., Smeyers-Verbeke J. Anal. Chim. Acta. 404:2000;257-271.
18. European Pharmacopoeia Commission: System Suitability Criterion for Repeatability, non-published document PA/PH/Exp. MG/T (01) 1, 2001.
19. S. Ebel, Latest developments of general separation methods, lecture given at the Conference 'The Future Face of the European Pharmacopoeia - Current Concerns in Pharmaceutical Analysis', 8-9, February 2001, Cannes, France.
20. Massart D.L., Vandeginste B.G.M., Buydens L.M.C., de Jong S., Lewi P.J., Smeyers-Verbeke J. Handbook of Chemometrics and Qualimetrics Part A. 1997;109-114 Elsevier, Amsterdam.
21. Center for Drug Evaluation and Research (CDER): Reviewer Guidance, Validation of Chromatographic Methods, FDA, Rockville, MD, November 1994, available from http://www.fda.gov/cder/guidance/cmc3.pdf, as given in December 2001.